1. Khan AA, Colquhoun A, Hanley DA, et al. Standards and guidelines for technologists performing central dual-energy X-ray absorptiometry. J Clin Densitom 2007;10:189-195.
2. National Osteoporosis Foundation. Clinician's guide to prevention and treatment of osteoporosis. Washington, DC: National Osteoporosis Foundation; 2010.
3. Rorabeck CH, Bourne RB, Nott L. The cemented kinematic-II and the non-cemented porous-coated anatomic prostheses for total knee replacement. A prospective evaluation. J Bone Joint Surg Am 1988;70:483-490.
5. Raisz LG. Local and systemic factors in the pathogenesis of osteoporosis. N Engl J Med 1988;318:818-828.
7. Hannan MT, Anderson JJ, Zhang Y, et al. Bone mineral density and knee osteoarthritis in elderly men and women. The Framingham Study. Arthritis Rheum 1993;36:1671-1680.
8. Hahn MH, Ahn JY, Lee KS. Bone mineral density differences of both hips in women with knee osteoarthritis over the age of 65. Korean J Bone Metab 2010;17:87-93.
11. Gazdzik TS, Gajda T, Kaleta M. Bone mineral density changes after total knee arthroplasty: one-year follow-up. J Clin Densitom 2008;11:345-350.
12. Ishii Y, Yagisawa K, Ikezawa Y. Changes in bone mineral density of the proximal femur after total knee arthroplasty. J Arthroplasty 2000;15:519-522.
13. Soininvaara TA, Miettinen HJ, Jurvelin JS, et al. Bone mineral density in the proximal femur and contralateral knee after total knee arthroplasty. J Clin Densitom 2004;7:424-431.
14. Bergink AP, van der Klift M, Hofman A, et al. Osteoarthritis of the knee is associated with vertebral and nonvertebral fractures in the elderly: the Rotterdam Study. Arthritis Rheum 2003;49:648-657.
15. Arden NK, Crozier S, Smith H, et al. Knee pain, knee osteoarthritis, and the risk of fracture. Arthritis Rheum 2006;55:610-615.
16. Joshi N, Pidemunt G, Carrera L, et al. Stress fracture of the femoral neck as a complication of total knee arthroplasty. J Arthroplasty 2005;20:392-395.
17. Prieto-Alhambra D, Javaid MK, Maskell J, et al. Changes in hip fracture rate before and after total knee replacement due to osteoarthritis: a population-based cohort study. Ann Rheum Dis 2011;70:134-138.
18. Shanbhag AS. Use of bisphosphonates to improve the durability of total joint replacements. J Am Acad Orthop Surg 2006;14:215-225.
19. Carulli C, Civinini R, Matassi F, et al. The use of anti-osteoporosis drugs in total knee arthroplasty. Aging Clin Exp Res 2011;23:38-39.
20. Wang CJ, Wang JW, Ko JY, et al. Three-year changes in bone mineral density around the knee after a six-month course of oral alendronate following total knee arthroplasty. A prospective, randomized study. J Bone Joint Surg Am 2006;88:267-272.
22. Lee JK, Choi CH, Kang CN. Quantitative computed tomography assessment of bone mineral density after 2 years' oral bisphosphonate treatment in postmenopausal osteoarthritis patients who underwent total knee arthroplasty. J Int Med Res 2013;41:878-892.
23. Prieto-Alhambra D, Javaid MK, Judge A, et al. Bisphosphonate use and risk of post-operative fracture among patients undergoing a total knee replacement for knee osteoarthritis: a propensity score analysis. Osteoporos Int 2011;22:1555-1571.